Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells.

Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells.

Item
http://www.wikidata.org/entity/Q39927757
Preclinical validation of interleukin 6 as a therapeutic target in multiple myelomaSelective glucocorticoid receptor-activating adjuvant therapy in cancer treatmentsVimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesWithaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivoSerum markers of apoptosis decrease with age and cancer stage.Establishment and characterization of bortezomib-resistant U266 cell line: constitutive activation of NF-κB-mediated cell signals and/or alterations of ubiquitylation-related genes reduce bortezomib-induced apoptosisWithaferin A Inhibits STAT3 and Induces Tumor Cell Death in Neuroblastoma and Multiple MyelomaDrugs acting on homeostasis: challenging cancer cell adaptation.Bortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cells.Natural and synthetic α,β-unsaturated carbonyls for NF-κB inhibition.Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.Soluble CD54 induces human endothelial cells ex vivo expansion useful for cardiovascular regeneration and tissue engineering application.Doxycycline speeds up healing of chronic venous ulcers.Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin.
P2860

Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells.

Item
http://www.wikidata.org/entity/Q39927757
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Simultaneous inhibition of the ...... e of human U266 myeloma cells.
@en
Simultaneous inhibition of the ...... e of human U266 myeloma cells.
@nl
type
label
Simultaneous inhibition of the ...... e of human U266 myeloma cells.
@en
Simultaneous inhibition of the ...... e of human U266 myeloma cells.
@nl
prefLabel
Simultaneous inhibition of the ...... e of human U266 myeloma cells.
@en
Simultaneous inhibition of the ...... e of human U266 myeloma cells.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Simultaneous inhibition of the ...... e of human U266 myeloma cells.
@en
P2093
P304
P31
P356
P433
P478
P577
P698